Asuragen Sets Sights on Pancreatic Cancer Screen Through TGen Collaboration
Asuragen this week announced that it has signed a deal to work with the Translational Genomics Research Institute to develop a test to detect pancreatic cancer using blood-based microRNAs as biomarkers.

Read more on GenomeWeb News